The emerging role of targeted therapy for hematologic malignancies: Update on bortezomib and tipifarnib

JP Armand, AK Burnett, J Drach, JL Harousseau, Bob Löwenberg, JS Miguel

Research output: Contribution to journalArticleAcademic

33 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)281-290
Number of pages10
JournalOncologist
Volume12
Issue number3
DOIs
Publication statusPublished - 2007

Cite this